Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,000 across all filing types
Latest filing 2023-02-22 Annual Report
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
2022_Full-Year_Integrated_Annual_Report_0.pdf
Annual Report Classification · 1% confidence The document is explicitly titled 'Integrated Annual Report 2022' and contains comprehensive sections including management reports, consolidated financial statements, notes to the financial statements, auditor's reports, and corporate governance statements. It covers the full fiscal year 2022 and provides detailed financial and extra-financial performance data, fitting the definition of an Annual Report (10-K). FY 2022
2023-02-22 English
2022_Full-Year_Integrated_Annual_Report-FR.pdf
Annual Report Classification · 1% confidence The document is titled 'Rapport annuel intégré 2022' (2022 Integrated Annual Report) for UCB. It contains comprehensive financial statements, management reports, governance disclosures, and audit reports for the full fiscal year 2022. It is clearly the primary annual reporting document rather than an announcement or a summary, fitting the definition of a 10-K (Annual Report). FY 2022
2023-02-22 French
2022_Full-Year_Integrated_Annual_Report-NL.pdf
Annual Report Classification · 1% confidence The document is titled 'Geïntegreerd jaarverslag 2022' (Integrated Annual Report 2022) for UCB. It contains comprehensive financial statements, management reports, governance disclosures, and audit reports for the full fiscal year 2022. It is clearly the primary annual reporting document, not an announcement or a summary, and thus fits the definition of a 10-K (Annual Report). FY 2022
2023-02-22 Dutch
21380029O1RSZIAVOR95-2022-12-31-en.xhtml
Annual Report Classification · 1% confidence The document is explicitly titled 'Integrated Annual Report 2022' and contains comprehensive sections including a management report, consolidated financial statements, notes to the financial statements, auditor's report, and corporate governance disclosures. It covers the full fiscal year 2022 and provides detailed financial and extra-financial performance data, fitting the definition of an Annual Report (10-K). FY 2022
2023-02-22 English
21380029O1RSZIAVOR95-2022-12-31-en (1).zip
Annual Report (ESEF) Classification · 1% confidence FY 2022
2023-02-22 English
21380029O1RSZIAVOR95-2022-12-31-fr.xhtml
Annual Report Classification · 1% confidence The document is explicitly titled 'Rapport annuel intégré 2022' (Integrated Annual Report 2022) for UCB. It contains comprehensive financial statements, management reports, governance disclosures, and audit reports for the full fiscal year 2022. It meets the criteria for a full Annual Report (10-K equivalent in this context). FY 2022
2023-02-22 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.